Cipla Q2FY25 Highlights - Umang Vohra
Cipla Q2FY25 Highlights - Umang Vohra, MD & CEO, Cipla - “ We are 89, we have a very strong legacy and we are constantly building for the future. Cipla is an institution, and we will continue to provide high quality medicines for patients across the world.
Part of what institutions also do is to leave the world a better place. We continue to create the right set of environmental metrics, to make sure that our planet is better for the children that follow, and also to make sure that we create an inclusive and diverse workplace, all of which is what Cipla has done.”